Form 4: Astronics Corp Executive James Mulato Reports Stock Bonus Award and Transactions
SEC Form 4
James Mulato, President of Astronics Test Systems, reports a stock bonus award, tax withholding, and 401(k) contribution affecting his beneficial ownership of Astronics Corp stock and derivative securities.
Summary
- On May 14, 2024, James Mulato, President of Astronics Test Systems, filed a Form 4 detailing changes in his beneficial ownership of Astronics Corp securities.
- Mulato received a stock bonus award of 286 shares of common stock on May 10, 2024, as part of the 2024 bonus plan, in lieu of a cash payment for Q1 2024 performance.
- 70 shares were withheld to cover applicable withholding taxes related to the stock bonus award on May 10, 2024.
- On May 13, 2024, 165.078 shares were added to Mulato's account in the issuer stock fund included in the issuer's 401(k) plan at a price of $18.89 per share.
- The report also details Mulato's ownership of various options and restricted stock units (RSUs) with different vesting schedules and performance-based conditions tied to Astronics Corp.'s average annual adjusted EBITDA.
- The vesting of RSUs depends on Astronics Corp.'s average annual adjusted EBITDA for various periods, including January 1, 2021 December 31, 2023; January 1, 2022 December 31, 2024; January 1, 2023 December 31, 2025; and January 1, 2024 December 31, 2026.
- The number of RSUs that may vest ranges from 50% to 150% of the target number, depending on actual performance against the EBITDA targets.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The stock bonus award and 401(k) contribution are positive indicators, but the dependence on EBITDA performance introduces some uncertainty.
Positives
- The stock bonus award reflects Astronics Corp.'s decision to compensate executives with company stock, aligning their interests with shareholders.
- The 401(k) contribution represents an additional benefit for the executive.
Negatives
- The withholding of shares for taxes reduces the immediate benefit of the stock bonus award.
Risks
- The vesting of RSUs is contingent on Astronics Corp.'s future financial performance, specifically its average annual adjusted EBITDA, which introduces uncertainty.
- Failure to meet the EBITDA targets could result in a lower percentage of RSUs vesting.
Future Outlook
The vesting of a significant portion of Mulato's equity compensation is tied to the company's future adjusted EBITDA performance, indicating a focus on long-term financial goals.
Industry Context
Executive compensation packages often include stock options and RSUs to align management's interests with those of shareholders, and this filing reflects that practice at Astronics Corp.
Comparison to Industry Standards
- Stock-based compensation is a common practice in publicly traded companies to incentivize executives and align their interests with shareholders.
- The use of EBITDA as a performance metric for vesting RSUs is also a standard practice, as it reflects the company's operational profitability.
- Companies like HEICO Corporation and TransDigm Group, known for their performance in the aerospace and defense sectors, also utilize similar compensation structures with performance-based equity grants.
Stakeholder Impact
- Shareholders: The stock bonus award aligns executive interests with shareholder value.
- Employees: The 401(k) contribution is a benefit for the executive.
- Executive: The executive's compensation is tied to the company's performance.
Next Steps
- Monitor Astronics Corp.'s financial performance to assess the likelihood of RSU vesting.
- Track future Form 4 filings to observe any further changes in Mulato's beneficial ownership.
Key Dates
| Date | Description |
|---|---|
| 12/11/2015 | Date of option grant with exercise price of $30.83 |
| 03/31/2015 | Date of option grant with exercise price of $34.75 |
| 12/03/2016 | Date of option grant with exercise price of $27.72 |
| 12/14/2017 | Date of option grant with exercise price of $31.76 |
| 12/12/2018 | Date of option grant with exercise price of $35.61 |
| 12/13/2019 | Date of option grant with exercise price of $31.57 |
| 12/09/2020 | Date of option grant with exercise price of $30.04 |
| 01/22/2022 | Date of option grant with exercise price of $14.45 |
| 12/09/2022 | Date of option grant with exercise price of $11.13 |
| 12/16/2023 | Date of option grant with exercise price of $9.74 |
| 01/01/2021 | Start date for EBITDA performance period for certain RSUs |
| 01/01/2022 | Start date for EBITDA performance period for certain RSUs |
| 01/01/2023 | Start date for EBITDA performance period for certain RSUs |
| 01/01/2024 | Start date for EBITDA performance period for certain RSUs |
| 03/31/2024 | Expiration date for certain options |
| 05/10/2024 | Date of stock bonus award and tax withholding |
| 05/13/2024 | Date of 401(k) contribution |
| 05/14/2024 | Date of Form 4 filing |
| 12/07/2024 | Expiration date for certain options |
| 12/11/2024 | Expiration date for certain options |
| 12/14/2026 | Expiration date for certain options |
| 02/22/2027 | Potential vesting date for certain RSUs |
| 12/12/2027 | Expiration date for certain options |
| 12/13/2028 | Expiration date for certain options |
| 12/09/2029 | Expiration date for certain options |
| 01/22/2031 | Expiration date for certain options |
| 12/09/2031 | Expiration date for certain options |
| 12/16/2032 | Expiration date for certain options |
| 12/07/2033 | Expiration date for certain options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.